These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Differential changes of retina dopamine binding sites and adenylyl cyclase responses following 6-hydroxydopamine treatment. Hadjiconstantinou M; Qu ZX; Neff NH Brain Res; 1991 Jan; 538(2):193-5. PubMed ID: 1849436 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of postsynaptic dopamine-sensitive adenylate cyclase in carp retina by the putative dopamine autoreceptor agonist, 3-PPP. Watling KJ; Jones JH; Williams M Eur J Pharmacol; 1982 Aug; 82(1-2):117-8. PubMed ID: 6290231 [No Abstract] [Full Text] [Related]
8. A dopaminergic-cholinergic mechanism in production of psychotic symptoms. Friedhoff AJ; Alpert M Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131 [No Abstract] [Full Text] [Related]
9. Biochemical characterization of the dopamine receptor in the mammalian caudate nucleus. Greengard P J Psychiatr Res; 1974; 11():87-90. PubMed ID: 4156795 [No Abstract] [Full Text] [Related]
10. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation. Bourgoin S; Adrien J; Laguzzi RF; Dolphin A; Bockaert J; Hery F; Hamon M Brain Res; 1979 Jan; 160(3):461-78. PubMed ID: 421125 [No Abstract] [Full Text] [Related]
11. The anterior amygdala dopamine sensitive adenylate cyclase: point of action of antipsychotic drugs. Racagni G; Carenzi A Pharmacol Res Commun; 1976 Apr; 8(2):149-57. PubMed ID: 17869 [No Abstract] [Full Text] [Related]
12. Modification of the receptor component of adenylate cyclase in the rat brain by phenothiazine derivatives. Palmer GC; Manian AA Neuropharmacology; 1974 Sep; 13(9):851-66. PubMed ID: 4154419 [No Abstract] [Full Text] [Related]
13. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Creese I; Burt DR; Snyder SH Science; 1976 Apr; 192(4238):481-3. PubMed ID: 3854 [TBL] [Abstract][Full Text] [Related]
14. Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina. Brown JH; Makman MH Proc Natl Acad Sci U S A; 1972 Mar; 69(3):539-43. PubMed ID: 4401122 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the dopamine-mediated accumulation of cyclic AMP in intact retina of rabbit. Schorderet M Life Sci; 1977 May; 20(10):1741-7. PubMed ID: 17798 [No Abstract] [Full Text] [Related]
16. Amphetamine normalizes reserpine-induced supersensitivity of the noradrenaline receptor coupled adenylate cyclase system in brain. Gillespie DD; Manier DH; Sulser F J Pharm Pharmacol; 1980 Jul; 32(7):503-4. PubMed ID: 6105190 [No Abstract] [Full Text] [Related]
17. The pharmacologic meaning of successful antipsychotic-antidepressant combinations. Extein I; Bowers MB Compr Psychiatry; 1975; 16(5):427-34. PubMed ID: 240642 [No Abstract] [Full Text] [Related]
18. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia. Kety SS Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537 [No Abstract] [Full Text] [Related]
19. Narcotic dependence, narcotic action and dopamine receptors. Lal H Life Sci; 1975 Aug; 17(4):483-95. PubMed ID: 171531 [No Abstract] [Full Text] [Related]
20. Basic and clinical studies of endorphins. Ann Intern Med; 1979 Aug; 91(2):239-50. PubMed ID: 37796 [No Abstract] [Full Text] [Related] [Next] [New Search]